Objectives In this study, we analysed the expression of chitotriosidase (CHIT1) and acidic mammalian chitinase (AMCase) genes in human gastric mucosa biopsies to establish the function of the corresponding enzymes in patients with gastritis associated or not with Helicobacter pylori infection.
Introduction
Chitin is a nitrogen polysaccharide composed of N-acetyl-Dglucosamine units, which are linked by b-(1-4)-glycosidic bonds [1] . After cellulose, chitin is the second most abundant biopolymer on Earth. It is present as a structural component of many organisms, such as the cell wall of most fungi and yeasts, the microfilarial sheath of parasitic nematodes and the exoskeleton of all types of arthropods. It is also synthesized at small quantity by different molluscs, marine diatoms and algae [2, 3] .
Chitinases are glycosyl hydrolases (GH) that catalyse the degradation of the b-(1-4)-glycosidic bonds of chitin [3] . Chitinases are divided into endochitinases [4] that hydrolyze chitin bonds from the middle of the polysaccharide chain, and exochitinases [5] that degrade only the nonreducing end of the molecule [6] .
The typical structure of a chitinase consists of a signal peptide, a glycohydrolase domain and a chitin-binding domain. However, most of these proteins have been found to lack chitinolytic activity because of mutations in the highly conserved catalytic domain [7] .
On the basis of amino acid sequence similarities within the catalytic domain, chitinases (GH) can be classified into two distinct families: family 18 (GH18) and family 19 (GH19) [8] . The members of the two families differ in their amino acid sequence, three-dimensional structure and biochemical mechanism of action and are thus considered to have different evolutionary origins [9] .
Humans are not able to synthesize chitin and only recently studies have been carried out on this subject: surprisingly, the human genome was found to encode at least eight GH18 chitinase genes [10, 11] . The first human enzyme with chitinolytic activity discovered is chitotriosidase (CHIT1 gene), located in chromosome 1q31-q32 [12] and secreted by activated macrophages [13] . Stimulated macrophages produce considerable amounts of CHIT1 mRNA. CHIT1 is synthesized and accumulated in specific granules of neutrophil precursors [14] .
CHIT1 was first described in plasma of patients affected with Gaucher's disease [13, 15] and now is currently considered the most important biochemical marker to diagnose and control the evolution of this disease and to monitor the success of therapeutic approaches [16] . A significant increase in the activity of this enzyme has been observed in the serum of patients with glucocerebrosidase, arteriosclerosis, sarcoidosis, b-thalassaemia [7] and in the plasma of patients with multiple sclerosis, acute cerebral ischaemia and Alzheimer's disease [17] . The observation that CHIT1 is able to degrade both colloidal chitin and chitin in the cell wall of the fungal pathogen Candida albicans has prompted the hypothesis that this enzyme could play a role in defence against chitinous human pathogens [6, 18] . This hypothesis is supported by several studies showing an elevated level of plasma CHIT1 in African children affected with malaria and in the colostrum of African women. Consequently, it has been suggested that CHIT1 may play a role in innate immunity and in host defence mechanisms against chitinous pathogens [19, 20] .
In 2001, Boot and colleagues [21] identified a second active chitinase in mammals characterized by an optimal pH around 2 and named it as acidic mammalian chitinase (AMCase). AMCase gene, also called CHIA, is located in chromosome 1p13. This enzyme is extremely acid stable and therefore it seems like to be apt to work in an extreme environment such as the stomach, where it can act in the defence against and in the digestion of organisms made of chitin [22] .
Several studies have shown relatively high levels of AMCase gene expression in mouse salivary gland and stomach, as well as in human gastric mucosa [23] and Paoletti et al. [24] , in 2007, analysed the chitinolytic activity of AMCase in human gastric juice.
AMCase is also expressed in lung tissue, and Zhu et al. [25] , in 2004, indeed demonstrated that the expression of AMCase by airway epithelia and pulmonary macrophages is dramatically upregulated both in a mouse model of asthma and in humans affected with allergic asthma. The exact mechanism by which this enzyme regulates Th2-driven inflammation in asthma is still unknown, although AMCase could be a potential novel target for anti-inflammatory therapy in Th2-mediated diseases such as asthma [4] .
In this study, we measure CHIT1 and AMCase genes expression in human gastric mucosa and test whether a correlation with inflammation and the presence of Helicobacter pylori exists.
Materials and methods

Patient selection and sample collection
Twenty-seven patients presenting with dyspeptic symptoms and postprandial pain were enrolled at the Surgical Endoscopy Unit, University Policlinic of Padova. All the experimental procedures, as well as blood, gastric juice and biopsies collection were approved by the local Ethics Committee of the Padova University Polyclinic. A statement of informed consent was signed by all the participants for the study. Patients underwent diagnostic gastrointestinal endoscopy and gastric biopsy. Patients with hepatic cirrhosis, HCV hepatitis, immunosuppressive disease and patients using anticoagulant drugs for at least 3 months before the examination were excluded from this study. Patients did not consume food for at least 12 h before gastroscopy. Endoscopy was performed under topic anaesthesia or conscious sedation using normal or paediatric fibroscopy. Personal data (age, sex, nationality and clinical history) were also collected.
Two antral fragments of gastric mucosa were taken from each patient. Biopsies were immediately collected in 5 ml of RNAlater Tissue Collection (Ambion, Austin, Texas, USA) solution. The samples were stored at 41C overnight. Biopsies were then weighed, transferred into a tube with 1 ml Trizol (Invitrogen, Carlsbad, California, USA) and stored at -801C until total RNA extraction.
All tubes containing the biopsies were identified with a progressive number, according to the assigned number in the database containing all the anthropological and medical data of the participants to the study (age, sex, nationality, gastroenterologic diseases, H. pylori detection, gastroscopic appearance of mucosa, general information on diet).
Stomach inflammation and Helicobacter pylori infection analysis
Antrum and corpus biopsy specimens of gastric mucosa were also taken from each patient to analyse stomach inflammation and to detect H. pylori infection.
Multiple sections (5 mm thick) were obtained from each formalin-fixed, paraffin-embedded tissue block. Slides were stained with hematoxylin and eosin (for gastritis assessment) and modified Giemsa (for detection of H. pylori). Each biopsy was given a gastritis score using a visual analogue scale (+ mild; ++ moderate; +++ severe), based on the Sydney System [26] .
When H. pylori was detected (as a Giemsa-positive bacillus), the result was registered in the final report and gastritis was classified as 'H. pylori related'.
In this study, we could not use a sample of noninflamed mucosa as a negative control, because all patients showed symptoms of gastric inflammation. It is extremely difficult to collect a sample of completely healthy gastric mucosa with gastroscopy. At present, we do not know whether these genes (AMCase and CHIT1) are only expressed in inflamed gastric mucosa or whether they are also expressed in noninflamed mucosa. We can only state that the levels of expression of these genes are different in the presence/absence of H. pylori infection and vary with the degree of mucosal inflammation.
Total RNA extraction and quantification
Tissue samples were homogenized in 1 ml of Trizol (Invitrogen) using a power homogenizer (Ultra-turrax-T8; IKA WERKE, Staufen, Germany). After incubation of the homogenized samples for 5 min at room temperature, 200 ml of chloroform was added. Samples were mixed vigorously and held on ice for 15 min, then centrifuged for 15 min at 16 100g at 41C. RNA was precipitated from the aqueous phase by adding an equal volume of isopropanol and then dissolved in RNase-free water.
For each sample, total RNA concentration was determined by spectrophotometrical analysis with NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, USA).
The quality of each sample was measured with the Agilent 2100 BioAnalyzer System (Agilent Technologies, Palo Alto, California, USA). Only good quality RNA was used for further experiments.
Quantitative polymerase chain reaction cDNA was prepared from 1 mg of total RNA using Superscript II (Invitrogen) and oligo(dT), following manufacturer's instructions.
Quantitative real-time PCR (qRT-PCR) based on SYBR Green chemistry (Applied Biosystems, Foster City, California, USA) was carried out to test the expression level of CHIT1 and AMCase. Fifty nanograms of cDNA, reverse-transcribed from total RNA, was amplified using the DyNAmo HS SYBR Green qPCR Kit (Finnzymes, Espoo, Finland). PCR reactions were carried out in a GeneAmp 9600 thermocycler, coupled with a GeneAmp 5700 Sequence Detection System (Applied Biosystems). Gene-specific oligonucleotides were designed using Primer 3 software (http://www-genome.wi.mit.edu/cgi-bin/primer/ primer3.cgi). CHIT1 primer sequences were designed according to the deposited mRNA reference sequence (GenBank accession no. NM_003465). CHIT1 primer sequences were 5 0 -GGGATGCTGGCCTACTATGA-3 0 (forward) and 5 0 -TAGGGCACCTTCTGATCCTG-3 0 (reverse). Primer sequences for AMCase were designed on the basis of the two deposited transcript variants (GenBank accession no. NM_021797 and NM_201653).
AMCase primer sequences were 5 0 -CTACGACCT CCATGGCTCCT-3 0 (forward) and 5 0 -TGCTCCATTG TCCTTCCAGT-3 0 (reverse) and were chosen to specifically identify both AMCase transcript variants.
To quantify CHIT1 and AMCase expression, we used the absolute quantification method, comparing patient samples to a standard curve [27] . The standard curves for each gene were constructed with five serial 10-fold dilutions of a purified and quantified PCR product (obtained with the same primers used for the qRT-PCR), with a sensitivity range of 7.4 Â 10 -2 -7.4 Â10 -5 pg (CHIT1) and 3.8 Â 10 -2 -3.8 Â 10 -6 pg (AMCase). The threshold cycle (Cts) obtained from patient's sample was compared with the Cts generated from the specific standard curve. Results were expressed in quantity (picograms) of specific amplified nucleic acid.
The equation used to calculate the 'pg' quantity of template (mRNA) that was present at the beginning of the qRT-PCR reaction was: pg ¼ 10 ðCtÀbÞ=a , where a = the angular coefficient (slope) and b = the intercept.
As the two genes we studied (CHIT1 and AMCase) were expressed at a very low level in the gastric mucosa, a classic qRT-PCR reaction (40 cycles) was not able to quantify the initial mRNA quantity. We then decided to stop the qRT-PCR reaction during the linear phase (i.e. after 10 amplification cycles), to add new mix (master mix and half concentration of primers) and to start with a second classic qRT-PCR reaction (40 cycles).
The linearity of the reaction was preserved (Supplemental Figs 1 and 2 ) and the sample Cts fell in the standard curve sensitivity range.
Polymerase chain reaction
PCR was used to generate known samples to construct the standard curve. PCR amplification was carried out in a 50-ml reaction volume [Tris-HCl 65.5 mmol/l, (NH 4 )SO 4 16 mmol/l, MgCl 2 1.5 mmol/l, and Tween 20, 0.01%], using 100 ng of cDNA, 200 mmol/l dNTPs, 16 pmol of each primer, and 1 U Taq polymerase. PCR conditions were as follows: 941C for 5 min, 35 cycles at 941C for 40 s, 601C for 30 s and 721C for 40 s, followed by a final elongation step at 721C for 6 min. Secondary PCR was made using 1 ml of the primary PCR, with the same condition as described above. PCR products were run on a 0.5% agarose gel, and the specific band was cut and purified using the GFX PCR DNA and Gel Band Purification kit (GE Healthcare, Chalfont St Giles, UK). Purified DNA was quantified using the NanoDrop ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies, Wilmington, USA).
CHIT1 and AMCase expression level in human gastric mucosa with the severity of stomach inflammation and the presence of H. pylori infection was analysed by the w 2 test, using a P value at the 0.05 significance level as cutoff.
Results
CHIT1 expression in human stomach
Twenty-four Caucasian and three foreign patients were selected and subjected to gastric biopsy. After total RNA purification, we investigated CHIT1 expression levels in the gastric mucosa from each patient. CHIT1 was expressed at low levels in the stomach of all the studied individuals except three, patients 12, 26 and 27, who showed no expression (Fig. 1) . In particular, CHIT1 mRNA quantity varied between 6.315 Â 10 -5 (minimum value, patient 8) and 6.220 Â 10 -3 pg (maximum value, patient 20), with a mean quantity of 5.427 Â 10 -4 ± 4.704 Â10 -5 pg.
Inflammation in the human stomach
Inflammation was also evaluated in the whole patients group (Table 1) . Under gastroendoscopic examination, almost all patients (21 out of 27, i.e. 77% of patients) had shown cardial incontinence and 44% (12 out of 27) of patients were suffering from gastritis.
Helicobacter pylori infection in the human stomach H. pylori infection was also evaluated in the whole patients group (Table 1) . Among the 27 patients considered, 11 patients showed infection with H. pylori, whereas 11 patients did not (five patients were excluded from this analysis, because no data were available).
CHIT1 gene expression correlates with inflammation and with Helicobacter pylori infection in the human stomach
We applied the w 2 test to assess whether, first, CHIT1 expression level and inflammation, and second, CHIT1 expression level and H. pylori infection, were independent variables.
In detail, CHIT1 expression was null in three patients, low in 13 patients, intermediate in five patients and high in six patients; inflammation was low in 16 patients, and high in seven patients (four patients were excluded from this analysis, because the inflammation status was not available). CHIT1 expression in gastric mucosa correlated with H. pylori infection (P = 0.026; Table 2 ). Furthermore, CHIT1 expression in gastric mucosa correlated with inflammation (P = 0.016; Table 3 ).
AMCase expression in human stomach
We studied the AMCase gene expression in the gastric mucosa from 27 patients. Quantitative RT-PCR confirmed the presence of AMCase mRNA in human gastric mucosa, even though this gene was expressed at a very low level (Fig. 2) . In particular, the majority of Quantitative real-time PCR of chitotriosidase (CHIT1) in stomach biopsies from 27 patients (grey: Caucasian patients; black: foreign patients). Patients 12, 26 and 27 showed no CHIT1 expression, whereas the CHIT1-specific mRNA mean quantity was 5.399 Â 10 -4 ± 4.887 Â 10 -5 pg. Absolute expression levels are shown in picograms (pg) of mRNA, based on a standard curve (see Materials and methods). Standard deviations calculated on the experimental replicates are also shown. our patients (19) 
pg).
AMCase expression in gastric mucosa did not correlate with H. pylori infection (P = 0.632; Table 4 ), nor with inflammation (P = 0.418; Table 5 ). The use of ' + ' refers to the gastritis severity score ( + mild; + + moderate; + + + severe) based on the Sydney System. /, data not available; EGDS, esophagogastroduodenoscopy; ND, data not described/test not executed. Table 2 Determination of relationship between positivity or negativity to Helicobacter pylori with the expression level of CHIT1 gene in human gastric mucosa 
Discussion
With this study we show, for the first time, that CHIT1 is expressed in the human stomach in the majority of patients (24 out of 27) presenting acute or chronic gastritis (12 out of 27), cardial incontinence (21 out of 27) and gastroesophageal reflux disease and, more broadly, dyspeptic symptoms and postprandial pain.
Considering that CHIT1 is secreted by activated macrophages [13, 19] and that all the involved participants suffered from some kind of inflammation/problem of the gastrointestinal tract, we present two hypotheses:
first, that CHIT1 is specifically secreted by activated macrophages that infiltrate the gastric mucosa during the inflammatory process; alternatively, that CHIT1 is also expressed by gastric mucosa cells. Further investigation is needed to answer this question. However, a positive correlation was shown between CHIT1 expression level and inflammation severity. This result could be explained through macrophage recruitment during the inflammatory response. Indeed, the patient showing the highest CHIT1 mRNA level (patient 20, with 6.220 Â 10 -3 ± 5.409 Â 10 -4 pg) suffered from gastritis and oesophageal candidiasis. An increase in CHIT1 enzyme quantity in blood from patients with Candida albicans infection has already been described [28] , suggesting that CHIT1 could play a role in human defence mechanisms against chitin-containing pathogens [18] . Moreover, patients with high CHIT1 mRNA quantity (patients 2, 10, 13, 14 and 15, with 6.770 Â10 -4 ± 9.966 Â10 -5 pg to 1.248 Â 10 -3 ± 5.038 Â 10 -5 pg) were all affected by gastritis and were positive to the H. pylori test, suggesting an important role for H. pylori in CHIT1 mRNA induction. In three patients (patients 12, 26 and 27), CHIT1 gene expression was not detected; these participants had only a mild stomach inflammation, compared with the remaining individuals, and the test for H. pylori was negative. The correlation between CHIT1 gene expression in human gastric mucosa and inflammation, and CHIT1 gene expression and H. pylori infection, suggests CHIT1 involvement in human inflammatory responses. Moreover, these results suggest a possible role for CHIT1 in the defence mechanisms against pathogens such as Candida albicans and possibly H. pylori.
Our study also confirms the presence of the AMCase mRNA in human gastric mucosa [21] . This is the first time that the AMCase expression level was quantified by qRT-PCR in human gastric mucosa. In all the 27 selected patients, AMCase was expressed at a low level, however, we observed some individual expression variability. Expression values varied from 3.668 Â 10 -6 ± 1.294 Â 10 -6 pg to 1.572 Â 10 -4 ± 2.568 Â 10 -5 pg, with a mean value of 2.698 Â 10 -5 ± 4.826 Â 10 -6 pg. In contrast to CHIT1, statistical analysis (w 2 test) showed no correlation between the AMCase expression and H. pylori infection. Moreover, no statistical significance was observed between AMCase expression and gastric inflammation severity. These results confirm the role of CHIT1 gene expression in patients with gastritis because of H. pylori, through macrophage activation in the presence of H. pylori. This interesting association hypothetically could suggest a protective mechanism on cancer development, as indicated by Pan et al. [29] and Malaguarnera et al. [30] have hypothesized for the population living in sub-Saharan area, where the wild-type CHIT1 allele is genetically prevalent [30] .
In fact, Pan et al. [31] have demonstrated that in vitro inoculation of chitinase, produced by Serrantia marcescens bacteria, lyses breast cancer cells in culture, and Cataldo et al. [32] , studying the prevalence of H. pylori in Burkina Faso population, found that high rate of infection among this population coincided with extremely low incidence of stomach cancer (African enigma). This absolutely novel observation of a correlation between CHIT1 gene expression and H. pylori infection needs further studies on selected populations where the presence of H. pylori is associated to cancer development.
In our future studies, we would like to collect some samples of noninflamed gastric mucosa in order to investigate whether a basal expression of these genes (especially CHIT1) is present and to measure the different expression levels between healthy and inflamed mucosa. CHIT1 expression could be considered a new parameter for the diagnosis of H. pylori gastric pathology.
